MX26715A - Procedimiento para la preparacion de particulas antigenicas del virus de la hepatitis b en levaduras metilotroficas. - Google Patents

Procedimiento para la preparacion de particulas antigenicas del virus de la hepatitis b en levaduras metilotroficas.

Info

Publication number
MX26715A
MX26715A MX2671589A MX2671589A MX26715A MX 26715 A MX26715 A MX 26715A MX 2671589 A MX2671589 A MX 2671589A MX 2671589 A MX2671589 A MX 2671589A MX 26715 A MX26715 A MX 26715A
Authority
MX
Mexico
Prior art keywords
hepatitis
virus
procedure
preparation
antigenic particles
Prior art date
Application number
MX2671589A
Other languages
English (en)
Spanish (es)
Inventor
Gregory Patrick Thill
Original Assignee
Phillips Petroleum Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phillips Petroleum Co filed Critical Phillips Petroleum Co
Publication of MX26715A publication Critical patent/MX26715A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
MX2671589A 1988-05-13 1989-05-12 Procedimiento para la preparacion de particulas antigenicas del virus de la hepatitis b en levaduras metilotroficas. MX26715A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19371488A 1988-05-13 1988-05-13

Publications (1)

Publication Number Publication Date
MX26715A true MX26715A (es) 1993-10-01

Family

ID=22714736

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2671589A MX26715A (es) 1988-05-13 1989-05-12 Procedimiento para la preparacion de particulas antigenicas del virus de la hepatitis b en levaduras metilotroficas.

Country Status (25)

Country Link
US (2) US5670630A (US20100012521A1-20100121-C00001.png)
EP (1) EP0341746B1 (US20100012521A1-20100121-C00001.png)
JP (1) JP2614314B2 (US20100012521A1-20100121-C00001.png)
KR (1) KR100193701B1 (US20100012521A1-20100121-C00001.png)
CN (1) CN1038668A (US20100012521A1-20100121-C00001.png)
AT (1) ATE151109T1 (US20100012521A1-20100121-C00001.png)
AU (1) AU618596B2 (US20100012521A1-20100121-C00001.png)
CA (1) CA1340617C (US20100012521A1-20100121-C00001.png)
DD (1) DD285373A5 (US20100012521A1-20100121-C00001.png)
DE (1) DE68927921T2 (US20100012521A1-20100121-C00001.png)
DK (1) DK235289A (US20100012521A1-20100121-C00001.png)
ES (1) ES2101676T3 (US20100012521A1-20100121-C00001.png)
FI (2) FI104639B (US20100012521A1-20100121-C00001.png)
GR (1) GR3023985T3 (US20100012521A1-20100121-C00001.png)
HU (1) HU207532B (US20100012521A1-20100121-C00001.png)
IE (1) IE81158B1 (US20100012521A1-20100121-C00001.png)
IL (1) IL90161A0 (US20100012521A1-20100121-C00001.png)
IN (1) IN171696B (US20100012521A1-20100121-C00001.png)
MX (1) MX26715A (US20100012521A1-20100121-C00001.png)
NO (1) NO300465B1 (US20100012521A1-20100121-C00001.png)
NZ (1) NZ228948A (US20100012521A1-20100121-C00001.png)
PL (1) PL161997B1 (US20100012521A1-20100121-C00001.png)
PT (1) PT90553A (US20100012521A1-20100121-C00001.png)
YU (1) YU98689A (US20100012521A1-20100121-C00001.png)
ZA (1) ZA893440B (US20100012521A1-20100121-C00001.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032516A (en) * 1985-10-25 1991-07-16 Phillips Petroleum Company Pichia pastoris alcohol oxidase II regulatory region
PL168787B1 (pl) * 1989-08-03 1996-04-30 Smithkline Beecham Biolog Sposób wytwarzania czastki kompozytowej PL
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
EP0521348A1 (en) * 1991-06-18 1993-01-07 Korea Institute Of Science And Technology Chimeric antibody with specificity for hepatitis B virus pre-S2 surface antigen and cell line producing same
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
CA2101610A1 (en) * 1992-08-07 1994-02-08 William D. Prevatt Production of bacillus entomotoxins in methylotrophic yeast
GB9402832D0 (en) * 1994-02-15 1994-04-06 Smith Kline Beecham Biolog S A Novel process
US5716808A (en) * 1995-11-09 1998-02-10 Zymogenetics, Inc. Genetic engineering of pichia methanolica
EP0889966A1 (en) * 1995-11-09 1999-01-13 ZymoGenetics, Inc. Compositions and methods for producing heterologous polypeptides in pichia methanolica
US5955349A (en) * 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
MX9605082A (es) 1996-10-24 1998-04-30 Univ Autonoma De Nuevo Leon Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
WO2006033679A2 (en) * 2004-05-25 2006-03-30 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system
CN1704475A (zh) * 2004-05-31 2005-12-07 成都生物制品研究所 羧端含前s2免疫决定簇的乙肝表面抗原融合基因及蛋白质
JP2008507266A (ja) * 2004-07-22 2008-03-13 グライコフィ, インコーポレイテッド ピチアにおける異種遺伝子発現のためのリンゴ酸シンターゼ調節配列
CN100381171C (zh) * 2004-12-30 2008-04-16 成都生物制品研究所 含前s1、前s2和s抗原决定簇的乙肝表面抗原复合颗粒
DE602007005366D1 (de) * 2006-04-07 2010-04-29 Chimeros Inc Zusammensetzungen und verfahren zur behandlung von b-zellen-malignomen
US20090226525A1 (en) * 2007-04-09 2009-09-10 Chimeros Inc. Self-assembling nanoparticle drug delivery system
WO2010120874A2 (en) 2009-04-14 2010-10-21 Chimeros, Inc. Chimeric therapeutics, compositions, and methods for using same
CA2847888A1 (en) 2011-09-09 2013-03-14 Biomed Realty, L.P. Methods and compositions for controlling assembly of viral proteins
CN110669746B (zh) 2012-10-23 2024-04-16 基因工具股份有限公司 用于切割靶dna的组合物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (US20100012521A1-20100121-C00001.png) * 1981-08-04 1984-08-04 Univ California
EP0171908A3 (en) * 1984-07-11 1987-07-15 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
JPS62236496A (ja) * 1986-04-07 1987-10-16 Green Cross Corp:The HBsAgの製造方法
US4963483A (en) * 1987-10-13 1990-10-16 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
IL89991A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of hepatitis b pres2 protein in methylotrophic yeasts

Also Published As

Publication number Publication date
HU207532B (en) 1993-04-28
IE81158B1 (en) 2000-05-03
NZ228948A (en) 1991-06-25
US5650296A (en) 1997-07-22
IN171696B (US20100012521A1-20100121-C00001.png) 1992-12-12
FI892312A0 (fi) 1989-05-12
US5670630A (en) 1997-09-23
FI107265B (fi) 2001-06-29
HUT52557A (en) 1990-07-28
DK235289A (da) 1989-11-14
NO300465B1 (no) 1997-06-02
EP0341746A3 (en) 1991-04-24
ZA893440B (en) 1990-01-31
FI19992546A (fi) 1999-11-29
DE68927921T2 (de) 1997-07-17
YU98689A (sh) 1992-07-20
CN1038668A (zh) 1990-01-10
ES2101676T3 (es) 1997-07-16
GR3023985T3 (en) 1997-10-31
JP2614314B2 (ja) 1997-05-28
FI892312A (fi) 1989-11-14
DE68927921D1 (de) 1997-05-07
NO891921D0 (no) 1989-05-11
AU618596B2 (en) 1992-01-02
IE891563L (en) 1989-11-13
FI104639B (fi) 2000-03-15
EP0341746A2 (en) 1989-11-15
NO891921L (no) 1989-11-14
PL279426A1 (en) 1990-01-22
EP0341746B1 (en) 1997-04-02
DD285373A5 (de) 1990-12-12
DK235289D0 (da) 1989-05-12
IL90161A0 (en) 1989-12-15
JPH0227990A (ja) 1990-01-30
KR890017361A (ko) 1989-12-15
PT90553A (pt) 1989-11-30
AU3473489A (en) 1989-11-16
PL161997B1 (pl) 1993-08-31
CA1340617C (en) 1999-06-29
KR100193701B1 (ko) 1999-06-15
ATE151109T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
MX26715A (es) Procedimiento para la preparacion de particulas antigenicas del virus de la hepatitis b en levaduras metilotroficas.
DE68929115D1 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
PH25120A (en) Replicable expression vehicle and process of preparation thereof
ES2053758T3 (es) Una nueva molecula polipeptidica.
DE68928380D1 (de) Expression von menschlichen Serumalbumin in methylotrophischen Hefen
PT73021A (en) Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
DE69324645D1 (de) Verfahren zur Herstellung von Hepatitis Antigenen und Impfstoffen
EP0299354A3 (en) Monoclonal antibodies against protein e7 of the human papilloma virus type 16, their production process and their use
ZA874677B (en) Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same
DK257887A (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
EP0503252A3 (en) Recombinant proteins having the immunoreactivity of hepatitis b virus e antigens (hbeag), method for their production and their application in immunoassays and as vaccines
ATE93891T1 (de) Reinigung von rekombiniertem hepatitis-boberfl|chen-antigen.
IE871743L (en) "dna sequence, recombinant dna molecules and process for¹producing the newcastle disease virus fusion protein or¹equivalent polypeptides, obtained products and preparations¹containing the same"